Cargando…

High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma

BACKGROUND: Intrahepatic cholangiocarcinoma (ICC) is malignancies of the biliary duct system and constitutes approximately 10%-20% of all primary liver cancers. Tumor mutation burden (TMB) is a useful biomarker across many cancer types for the identification of patients who will benefit from immunot...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Jian-Ping, Liu, Xue-Zhi, Chen, Qian, Liu, Yan-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790456/
https://www.ncbi.nlm.nih.gov/pubmed/35127895
http://dx.doi.org/10.12998/wjcc.v10.i3.790

Ejemplares similares